Pursuit or discontinuation of anti-PD1 after 2 years of treatment in long-term responder patients with non-small cell lung cancer.

Ardin, Camille; Humez, Sarah; Leroy, Vincent; Ampere, Alexandre; Bordier, Soraya; Escande, Fabienne; Turlotte, Amélie; Stoven, Luc; Nunes, David; Cortot, Alexis; Gauvain, Clément

Ardin, Camille; Humez, Sarah; Leroy, Vincent; Ampere, Alexandre; Bordier, Soraya; Escande, Fabienne; Turlotte, Amélie; Stoven, Luc; Nunes, David; Cortot, Alexis; Gauvain, Clément.

Afiliação

Ardin C; Service de Pneumologie-Oncologie Thoracique, Institut CÅur Poumon, Lille University Hospital, Boulevard du Professeur Jules Leclercq, Lille 59037, France.
Humez S; Service d'anatomo-pathologie, Lille University Hospital, Lille, France.
Leroy V; Service de Pneumologie, Clinique Tessier, Valenciennes, France.
Ampere A; Service de Pneumologie, Centre Hospitalier de Béthune, Beuvry, France.
Bordier S; Service de Pneumologie, Centre Hospitalier de Dunkerque, Dunkerque, France.
Escande F; Service de Biochimie -Biologie Moléculaire, Lille University Hospital, Lille, France.
Turlotte A; Service de Pneumologie, Centre Hospitalier d'Arras, Arras, France.
Stoven L; Service de Pneumologie, Centre Hospitalier de Boulogne, Boulogne-sur-mer, France.
Nunes D; Service de Pneumologie-Oncologie Thoracique, Institut CÅur Poumon, Lille University Hospital, Lille, France.
Cortot A; Service de Pneumologie, Centre hospitalier Victor Provo, Roubaix, France.
Gauvain C; Service de Pneumologie-Oncologie Thoracique, Institut CÅur Poumon, Lille University Hospital, Lille, France.

Ther Adv Med Oncol ; 15: 17588359231195600, 2023.

Article em En | MEDLINE | ID: mdl-37720494

Palavras-chave

ICI treatment duration; long-term responders; nivolumab; non-small cell lung cancer; pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google